发明名称 2,4-DI(HETERO-)ARYLAMINO(-OXY)-5-SUBSTITUTED PYRIMIDINE AS ANTINEOPLASTIC AGENT
摘要 PROBLEM TO BE SOLVED: To provide an antineoplastic agent which possess cell-cycle inhibitory activity and accordingly useful for their anti-cancer (such as anti-cell-proliferative, anti-cell migration and/or apoptotic) activity and are therefore useful in methods of treatment of a warm-blooded animal, such as human. SOLUTION: Pyrimidine derivatives of formula (I), (wherein Q<SB>1</SB>, Q<SB>2</SB>, G and R<SP>1</SP>are as defined in the specification), and pharmaceutically acceptable salts and in vivo hydrolysable esters thereof are provided. Processes for their manufacture, pharmaceutical compositions and their use as cyclin-dependent serine/threonine kinase (CDK) and focal adhesion kinase (FAK) inhibitors are also provided. COPYRIGHT: (C)2005,JPO&NCIPI
申请公布号 JP2005041878(A) 申请公布日期 2005.02.17
申请号 JP20040245381 申请日期 2004.08.25
申请人 ASTRAZENECA AB 发明人 PEASE ELIZABETH JANET;WILLIAMS EMMA JANE;BRADBURY ROBERT HUGH;PEARSON STUART ERIC
分类号 A61K31/505;A61K31/506;A61K31/5377;A61P35/00;A61P43/00;C07D239/48;C07D401/12;C07D403/12;C07D413/12;C07D453/02;C07D521/00;(IPC1-7):C07D239/48;A61K31/537 主分类号 A61K31/505
代理机构 代理人
主权项
地址